Fig. 5From: Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and responseIntegrative hypothesis for utility of TIGS and cell proliferation for treatment selection. Hypothesized relationship mechanism by which cell proliferation and tumor immunogenicity affect treatment responseBack to article page